Zynex(ZYXI)

Search documents
Zynex eyes FDA submission for NiCO oximeter as it expands portfolio of innovative medical devices
Proactiveinvestors NA· 2025-01-28 18:33
Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2][3] - The company focuses on medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - Proactive's news team delivers insights across various sectors including biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - Proactive is committed to adopting technology to enhance workflows and content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]
Zynex partners with VA to offer pain management solutions for veterans
Proactiveinvestors NA· 2024-12-17 15:16
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States
Prnewswire· 2024-12-17 14:15
Core Insights - Zynex, Inc. has announced a partnership with Veterans Affairs Medical Centers (VAMCs) to enhance access to noninvasive pain management solutions for veterans [1][4] - The VA spends over $112 billion annually on healthcare, servicing over 9 million enrolled veterans, presenting a significant market opportunity for Zynex [2][3] - Currently, less than 1% of Zynex's sales come from VAMCs, indicating substantial potential for sales expansion within the largest healthcare network in the U.S. [2][4] Company Overview - Zynex, founded in 1996, specializes in the development, manufacturing, marketing, and sale of medical devices for pain management and rehabilitation [5] - The company also produces non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for hospital use [5] Market Context - The Department of Veterans Affairs operates 171 VAMCs and over 1,100 outpatient facilities, alongside approximately 700 Military Treatment Facilities (MTFs) managed by the Department of Defense, creating a vast healthcare network for veterans and service members [3]
Zynex CEO outlines plans for 2025 after revenue milestone – ICYMI
Proactiveinvestors NA· 2024-12-13 21:36
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters
Prnewswire· 2024-12-12 14:15
ENGLEWOOD, Colo., Dec. 12, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced highlights from a recent study comparing its NiCO™ laser pulse oximeter to conventional LED pulse oximeters for the effects of skin pigmentation on SpO2 measurements conducted by the University of Californi ...
Zynex Announces Completion of Its Laser Pulse Oximetry Trial
Prnewswire· 2024-12-05 14:15
ENGLEWOOD, Colo., Dec. 5, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has completed its clinical verification trial for their NiCO™ pulse oximeter overseen by anesthesiologist Dr. David MacLeod at Duke University.Trial completion is a key milestone required by the FDA ...
Zynex Announces Open Oximetry Project Membership
Prnewswire· 2024-12-03 14:15
ENGLEWOOD, Colo., Dec. 3, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced its membership in the Collaborative Community of the independently led Open Oximetry Project as an industry member.The Open Oximetry Project, an initiative led by the University of California, San Francisco' ...
Zynex leverages multi-modality NexWave device to transform pain management
Proactiveinvestors NA· 2024-11-26 20:42
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Zynex(ZYXI) - 2024 Q3 - Earnings Call Transcript
2024-10-24 22:53
Zynex, Inc. (NASDAQ:ZYXI) Q3 2024 Earnings Conference Call October 24, 2024 4:15 PM ET Company Participants Quinn Callanan - IR Thomas Sandgaard - Chairman, President and CEO Dan Moorhead - CFO Donald Gregg - President, Monitoring Solutions Conference Call Participants Avi Dahan - RBC Capital Markets Jeffrey Cohen - Ladenburg Thalmann Yi Chen - H.C. Wainwright Operator Good afternoon, ladies and gentlemen. And welcome to the Zynex Third Quarter 2024 Earnings Conference Call. At this time, all participants a ...
Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates
ZACKS· 2024-10-24 22:11
Zynex Inc. (ZYXI) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 40%. A quarter ago, it was expected that this company would post earnings of $0.08 per share when it actually produced earnings of $0.04, delivering a surprise of -50%.Over the last four quarters, the company has surpas ...